| PET/CT Imaging and Radioimmunotherapy of Prostate Cancer | 2011/01/01 | English | 65 |
| The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology | 2011/07/01 | English | 65 |
| The Na+/I− symporter (NIS): imaging and therapeutic applications | 2004/01/01 | English | 64 |
| Methods for the Assessment of Small-Bowel and Colonic Transit | 2012/03/01 | English | 64 |
| Magnetic Resonance-Guided Positron Emission Tomography Image Reconstruction | 2013/01/01 | English | 64 |
| Software for image registration: Algorithms, accuracy, efficacy | 2003/07/01 | English | 63 |
| Respective Roles of Thyroglobulin, Radioiodine Imaging, and Positron Emission Tomography in the Assessment of Thyroid Cancer | 2006/07/01 | English | 63 |
| Nuclear Medicine and Diabetic Foot Infections | 2009/01/01 | English | 62 |
| Single-Photon Emission Computed Tomography/Computed Tomographyfor Sentinel Node Mapping in Breast Cancer | 2007/01/01 | English | 62 |
| The Role of Nuclear Medicine in the Detection of Acute Gastrointestinal Bleeding | 2006/04/01 | English | 61 |
| Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis | 2017/07/01 | English | 61 |
| An Update on Dual-Energy X-Ray Absorptiometry | 2010/01/01 | English | 61 |
| Update on 18F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Imaging of Squamous Head and Neck Cancers | 2005/10/01 | English | 60 |
| Radioiodine: The Classic Theranostic Agent | 2012/05/01 | English | 60 |
| Future Diagnostic Agents | 2009/01/01 | English | 59 |
| Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications | 2009/01/01 | English | 58 |
| Cardiac PET Perfusion: Prognosis, Risk Stratification, and Clinical Management | 2014/09/01 | English | 58 |
| Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation | 2021/11/01 | English | 58 |
| Accuracy and Precision of Radioactivity Quantification in Nuclear Medicine Images | 2012/05/01 | English | 58 |
| Three-Dimensional Imaging-Based Radiobiological Dosimetry | 2008/09/01 | English | 57 |
| FDG-PET Imaging in HIV Infection and Tuberculosis | 2013/09/01 | English | 57 |
| Use of Dual-Point Fluorodeoxyglucose Imaging to Enhance Sensitivity and Specificity | 2012/07/01 | English | 57 |
| The role of positron emission tomography in skeletal disease | 2001/01/01 | English | 57 |
| FDG PET Imaging in Sarcoidosis | 2013/11/01 | English | 56 |
| Recent advances in radionuclide therapy | 2001/10/01 | English | 55 |
| Hybrid Imaging (SPECT/CT and PET/CT)—Improving the Diagnostic Accuracy of Functional/Metabolic and Anatomic Imaging | 2009/07/01 | English | 55 |
| Initial Staging of Lymphoma With Positron Emission Tomography and Computed Tomography | 2005/07/01 | English | 55 |
| Cardiac Applications of 123I-mIBG Imaging | 2011/09/01 | English | 54 |
| Radionuclide Therapy of Metastatic Prostate Cancer | 2019/07/01 | English | 54 |
| Radiopharmaceuticals to image infection and inflammation | 2001/10/01 | English | 54 |